{
    "N/R/U": "U",
    "Applicant": "Alvotech USA Inc.",
    "BLA Number": "761343",
    "Proprietary Name": "Selarsdi",
    "Proper Name": "ustekinumab-aekn",
    "BLA Type": "351(k) Interchangeable",
    "Strength": "130MG/26ML (5MG/ML)",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "October 18, 2024",
    "Ref. Product Proper Name": "ustekinumab",
    "Ref. Product Proprietary Name": "Stelara",
    "Supplement Number": "2",
    "Submission Type": "Supplement",
    "License Number": "2225",
    "Product Number": "003",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null,
    "drug": [
        {
            "name": "ustekinumab-aekn",
            "drugbank_id": "https://go.drugbank.com/drugs/DB05679"
        }
    ]
}